Skip Navigation

European Heart Journal 2004 25(23):2143-2148; doi:10.1016/j.ehj.2004.08.026
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schut, A. F.C.
Right arrow Articles by van Duijn, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schut, A. F.C.
Right arrow Articles by van Duijn, C. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical research

Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects

Anna F.C. Schuta,b, Gysèle S. Bleuminka, Bruno H.Ch. Strickera, Albert Hofmana, Jacqueline C.M. Wittemana, Huibert A.P. Polsa,b, Jaap W. Deckersa,c, Jaap Deinumd and Cornelia M. van Duijna,*

a Genetic Epidemiology Unit, Departments of Epidemiology & Biostatistics, Eramus Medical Centre Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
b Department of Internal Medicine, Erasmus Medical Centre Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
c Department of Cardiology, Erasmus Medical Centre Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
d Department of Internal Medicine, University Medical Centre Radboud Nijmegen, The Netherlands

Received January 26, 2003; revised August 26, 2003; accepted August 3, 2004 * Corresponding author. Tel.: +31 104 087 394; fax: +31 104 089 406 (E-mail: c.vanduijn{at}erasmusmc.nl).

AIMS: Cardiac angiotensin-I converting enzyme (ACE) activity is influenced by the ACE I/D polymorphism. Evidence suggests that the DD-genotype may be a risk factor for cardiac hypertrophy and heart failure, especially in hypertensive subjects. We assessed the relation between the ACE I/D polymorphism and the risk of incident heart failure in normotensive and hypertensive subjects.

METHODS AND RESULTS: We investigated 4264 normotensive and 2174 hypertensive participants of the Rotterdam Study, a population based prospective cohort study. All subjects were available for follow-up from 1990 until 2000. Incidence rates (IR) of heart failure in normotensive subjects were the same over all genotype strata (10 per 1000 person-years). In hypertensive subjects, the IR increased with the number of D-alleles present (II: IR=13, ID: IR=18 and DD: IR=20 per 1000 person-years). Hypertensive subjects carrying the II-genotype did not have an increased risk of heart failure compared to normotensive II subjects. However, hypertensive subjects carrying one or two copies of the D-allele did have a significantly increased risk of heart failure (ID: RR: 1.4 (1.1–1.9) and DD: RR: 1.5 (1.2–2.1)).

CONCLUSION: Our findings suggest that the ACE I/D polymorphism may play a modifying role in the development of heart failure in hypertensive subjects.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. Nakano, H. Hori, M. Abe, H. Shibata, T. Arimura, T. Sasaoka, M. Sawabe, K. Chida, T. Arai, K.-i. Nakahara, et al.
Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3396 - H3403.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. Muthumala, H. Montgomery, J. Palmen, J. A. Cooper, and S. E. Humphries
Angiotensin-Converting Enzyme Genotype Interacts With Systolic Blood Pressure to Determine Coronary Heart Disease Risk in Healthy Middle-Aged Men
Hypertension, August 1, 2007; 50(2): 348 - 353.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Li, L. Zagato, T. Kuznetsova, G. Tripodi, G. Zerbini, T. Richart, L. Thijs, P. Manunta, J.-G. Wang, G. Bianchi, et al.
Angiotensin-Converting Enzyme I/D and {alpha}-Adducin Gly460Trp Polymorphisms: From Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome
Hypertension, June 1, 2007; 49(6): 1291 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Koch, W. Latz, M. Eichinger, C. Ganser, A. Schomig, and A. Kastrati
Genotyping of the Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism by the TaqMan Method
Clin. Chem., August 1, 2005; 51(8): 1547 - 1549.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.